1-20 of 36
Diane Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO5-09-04: Oncotype DX Breast Recurrence Score® analysis in early-stage breast cancer associated with CHEK2, ATM and PALB2 germline pathogenic variants

Fatma Akkoc Mustafayev, Angelica Gutierrez Barrera, Diane Liu, Banu Arun
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO5-09-04.
https://doi.org/10.1158/1538-7445.SABCS23-PO5-09-04
Published: 02 May 2024
View articletitled, Abstract PO5-09-04: Oncotype DX Breast Recurrence Score® analysis in early-stage breast cancer associated with CHEK2, ATM and PALB2 germline pathogenic variants
Journal Articles

Abstract HER2-04: HER2-04 Prevalence of HER2-low among Metastatic Breast Cancer Patients and Their Outcomes Compared to HER2 IHC 0

Akshara Singareeka Raghavendra, Diane Liu, Jason Mouabbi, Debu Tripathy
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): HER2-04.
https://doi.org/10.1158/1538-7445.SABCS22-HER2-04
Published: 01 March 2023
View articletitled, Abstract HER2-04: HER2-04 Prevalence of HER2-low among Metastatic Breast Cancer Patients and Their Outcomes Compared to HER2 IHC 0
Journal Articles

Abstract P3-02-04: Phase II study of Pembrolizumab Maintenance treatment in patients with HER2-negative inflammatory breast cancer (IBC) and triple-negative breast cancer (TNBC) after response to chemotherapy

Toshiaki Iwase, Angela Alexander, Vivian Chiv, Megumi Kai, Kumiko Kida, Charla Parker, Angela N. Marx, Evan Cohen, Hui Gao, James Reuben, Xiaoping Wang, Savitri Krishnamurthy, Diane Liu, Yu Shen, David Ramirez, Debu Tripathy, Daniel Booser, Clinton Yam, Vicente Valero, Bora Lim, Naoto T. Ueno, Jie S. Willey
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P3-02-04.
https://doi.org/10.1158/1538-7445.SABCS22-P3-02-04
Published: 01 March 2023
View articletitled, Abstract P3-02-04: Phase II study of Pembrolizumab Maintenance treatment in patients with HER2-negative inflammatory breast cancer (IBC) and triple-negative breast cancer (TNBC) after response to chemotherapy
Journal Articles

Abstract P3-02-03: A phase Ib trial of bintrafusp alfa and eribulin in patients with metastatic triple negative breast cancer (TNBC)

Senthil Damodaran, Diane Liu, Jill Schwartz, Vicente Valero, David Ramirez, Sadia Saleem, Naoto T. Ueno, Nuhad K. Ibrahim, Meghan S. Karuturi, Rashmi K. Murthy, Stacy Moulder, Jennifer K. Litton
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P3-02-03.
https://doi.org/10.1158/1538-7445.SABCS22-P3-02-03
Published: 01 March 2023
View articletitled, Abstract P3-02-03: A phase Ib trial of bintrafusp alfa and eribulin in patients with metastatic triple negative breast cancer (TNBC)
Journal Articles

Abstract PS8-12: Interim analysis of a phase I dose escalation study of topical bexarotene in women at high risk for breast cancer

Parijatham S Thomas, Anisha B Patel, Diane Liu, J. Jack Lee, Seema Khan, Miguel Muzzio, Alejandro Contreras, Lana Vornik, Eileen P Dimond, Marjorie Perloff, Brandy Heckman-Stoddard, Powel H Brown
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS8-12.
https://doi.org/10.1158/1538-7445.SABCS20-PS8-12
Published: 15 February 2021
View articletitled, Abstract PS8-12: Interim analysis of a phase I dose escalation study of topical bexarotene in women at high risk for breast cancer
Journal Articles

Abstract PS14-04: A picture worth a thousand words - “classic” inflammatory breast cancer (IBC) appearance associated with overall survival

Wintana Balema, Diane Liu, Yu Shen, Randa El-Zein, Megumi Kai, Beth Overmoyer, Kathy D Miller, Carisa Le-Petross, Naoto T Ueno, Wendy A Woodward
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS14-04.
https://doi.org/10.1158/1538-7445.SABCS20-PS14-04
Published: 15 February 2021
View articletitled, Abstract PS14-04: A picture worth a thousand words - “classic” inflammatory breast cancer (IBC) appearance associated with overall survival
Journal Articles

Abstract OT1-02-02: A pilot study to examine the feasibility of measuring CTC and inflammatory biomarker changes resulting from atorvastatin as adjuvant therapy in TNBC and TN-IBC patients with residual disease after neoadjuvant chemotherapy

Angela Alexander, Takeo Fujii, Michael C Stauder, Wendy A Woodward, James M Reuben, Yu Shen, Diane Liu, Sangeetha M Reddy, Vicente Valero, Susan C Gilchrist, Bora Lim, Anthony Lucci, Naoto T Ueno, Carlos H Barcenas
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): OT1-02-02.
https://doi.org/10.1158/1538-7445.SABCS19-OT1-02-02
Published: 15 February 2020
View articletitled, Abstract OT1-02-02: A pilot study to examine the feasibility of measuring CTC and inflammatory biomarker changes resulting from atorvastatin as adjuvant therapy in TNBC and TN-IBC patients with residual disease after neoadjuvant chemotherapy
Journal Articles

Abstract OT3-15-02: A randomized, double-blind, placebo-controlled study of 4-hydroxytamoxifen topical gel in women with mammographically dense breasts

Banu K. Arun, Gretchen Gierach, Marion E Scoggins, Seema Khan, Sandra S Rao, Judy Garber, Sughra Raza, Nagi B. Kumar, Heather H Han, John Heine, Bethany Niell, Pavani Chalasani, Kimberly Fitzpatrick, Lee G Wilke, Amy Fowler, Heather C Beckwith, Carrie Mays, Saba Abutaseh, Lana Vornik, Oukseub Lee, Eileen Dimond, Marjorie Perloff, Diane Liu, J. Jack Lee, Powell Brown, Brandy Heckman-Stoddard
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): OT3-15-02.
https://doi.org/10.1158/1538-7445.SABCS19-OT3-15-02
Published: 15 February 2020
View articletitled, Abstract OT3-15-02: A randomized, double-blind, placebo-controlled study of 4-hydroxytamoxifen topical gel in women with mammographically dense breasts
Journal Articles

Abstract OT1-04-03: Alternative dosing of exemestane before surgery in postmenopausal patients with stage 0-II estrogen receptor positive breast cancer: Design and methodology

Aliana Guerrieri-Gonzaga, Parjhitham Thomas, Andrea DeCensi, Katherine D Crew, Nagi Kumar, Sara Gandini, Lana Vornik, Brandy Heckman-Stoddard, Eva Szabo, Eileen Dimond, Jack Lee, Diane Liu, Matteo Lazzeroni, Sara Cagnacci, Davide Serrano, Mauro D'Amico, Flavio Guasone, Tania Buttiron Webber, Powel Brown, Bernardo Bonanni
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): OT1-04-03.
https://doi.org/10.1158/1538-7445.SABCS19-OT1-04-03
Published: 15 February 2020
View articletitled, Abstract OT1-04-03: Alternative dosing of exemestane before surgery in postmenopausal patients with stage 0-II estrogen receptor positive breast cancer: Design and methodology
Journal Articles

Abstract CT033: Phase I study of intraventricular infusions of autologous exvivo expanded NK cells in children with recurrent/refractory malignant posterior fossa tumors of the central nervous system

Soumen Khatua, Vidya Gopalakrishnan, Laurence Cooper, Dean Lee, David I. Sandberg, Michael Rytting, Jason J. Johnson, Leena Ketonen, Diane Liu, Judy Moyes, Wafik Zaky
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): CT033.
https://doi.org/10.1158/1538-7445.AM2017-CT033
Published: 01 July 2017
View articletitled, Abstract CT033: Phase I study of intraventricular infusions of autologous exvivo expanded NK cells in children with recurrent/refractory malignant posterior fossa tumors of the central nervous system
Journal Articles

Abstract 4662: Beta blockers abrogate EGFR TKI resistance induced by adrenergic receptor-mediated upregulation of IL-6 and modulation of the LKB1/AMPK/mTOR axis

Monique B. Nilsson, Huiying Sun, Lixia Diao, Pan Tong, Youhong Fan, Hai Tran, Diane Liu, Guillermo Armaiz Pena, Jing Wang, Phil Rowe, Alan Webster, Jack Lee, Daniel Gomez, Waun Ki Hong, Ignacio Wistuba, Anil Sood, John Heymach
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4662.
https://doi.org/10.1158/1538-7445.AM2016-4662
Published: 15 July 2016
View articletitled, Abstract 4662: Beta blockers abrogate EGFR TKI resistance induced by adrenergic receptor-mediated upregulation of IL-6 and modulation of the LKB1/AMPK/mTOR axis
Journal Articles

Abstract 3970: EGF has stimulatory and survival effects in osteosarcoma in vitro and pan-ERBB kinase inhibition causes cell growth inhibition in vitro and reduces lung metastases in vivo

Laura D. Nelson, Tiffany N. Lynch, Yanwen Yang, Wei-Lien Wang, Diane Liu, Dafydd G. Thomas, Dennis P. M. Hughes
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 3970.
https://doi.org/10.1158/1538-7445.AM2014-3970
Published: 01 October 2014
View articletitled, Abstract 3970: EGF has stimulatory and survival effects in osteosarcoma in vitro and pan-ERBB kinase inhibition causes cell growth inhibition in vitro and reduces lung metastases in vivo
Journal Articles

Abstract 1716: Targeting the insulin-like growth factor receptor/Insulin receptor and Src signaling network for the treatment of non-small cell lung cancer

Hye-Young Min, Hye Jeong Yun, Hyo-Jong Lee, Jaebeom Cho, Hyun-Ji Jang, Kyung Min Kim, Woo-Young Kim, Seung-Hyun Oh, Diane Liu, J. Jack Lee, Waun K. Hong, Ignacio I. Wistuba, Ho-Young Lee
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1716.
https://doi.org/10.1158/1538-7445.AM2014-1716
Published: 01 October 2014
View articletitled, Abstract 1716: Targeting the insulin-like growth factor receptor/Insulin receptor and Src signaling network for the treatment of non-small cell lung cancer
Journal Articles

Abstract 5638: Preclinical evidence supporting cotargeting insulin-like growth factor receptor (IGF-1R) and Src in non-small cell lung cancer.

Jin-Soo Kim, Hye-Young Min, Hye Jeong Yun, Hyun-Ji Jang, Edward S. Kim, Diane Liu, J. Jack Lee, Carmen Behrens, Scott M. Lippman, Waun Ki Hong, Ignacio I. Wistuba, Ho-Young Lee
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5638.
https://doi.org/10.1158/1538-7445.AM2013-5638
Published: 15 April 2013
View articletitled, Abstract 5638: Preclinical evidence supporting cotargeting insulin-like growth factor receptor (IGF-1R) and Src in non-small cell lung cancer.
Journal Articles

CXCR2 Expression in Tumor Cells Is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma

Pierre Saintigny, Erminia Massarelli, Steven Lin, Young-Ho Ahn, Yulong Chen, Sangeeta Goswami, Baruch Erez, Michael S. O'Reilly, Diane Liu, J. Jack Lee, Li Zhang, Yuan Ping, Carmen Behrens, Luisa M. Solis Soto, John V. Heymach, Edward S. Kim, Roy S. Herbst, Scott M. Lippman, Ignacio I. Wistuba, Waun Ki Hong, Jonathan M. Kurie, Ja Seok Koo
Journal: Cancer Research
Cancer Res (2013) 73 (2): 571–582.
https://doi.org/10.1158/0008-5472.CAN-12-0263
Published: 16 January 2013
View articletitled, CXCR2 Expression in Tumor Cells Is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma
Open the PDF for CXCR2 Expression in Tumor Cells Is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract 392: CXCR2 expression in tumor cells is associated with an adverse outcome in a large set of non-small-cell lung cancer (NSCLC)

Pierre Saintigny, Diane Liu, J. Jack Lee, Yuan Ping, Carmen Behrens, Luisa M. Solis Soto, John V. Heymach, Edward S. Kim, Waun Ki Hong, Jonathan M. Kurie, Ignacio I. Wistuba, Ja Seok Koo
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 392.
https://doi.org/10.1158/1538-7445.AM2011-392
Published: 15 April 2011
View articletitled, Abstract 392: CXCR2 expression in tumor cells is associated with an adverse outcome in a large set of non-small-cell lung cancer (NSCLC)
Journal Articles

Abstract 3674: Gene expression analysis of field of cancerization in early stage NSCLC patients towards development of biomarkers for personalized prevention

Humam Kadara, Pierre Saintigny, Youhong Fan, Chi-Wan Chow, ZuoMing Chu, Wenhua Lang, Carmen Behrens, Kathryn Gold, Diane Liu, J. Jack Lee, Li Mao, Edward S. Kim, Waun K. Hong, Ignacio I. Wistuba
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 3674.
https://doi.org/10.1158/1538-7445.AM2011-3674
Published: 15 April 2011
View articletitled, Abstract 3674: Gene expression analysis of field of cancerization in early stage NSCLC patients towards development of biomarkers for personalized prevention
Journal Articles

Abstract 2203: Implication of GPRC5A loss in lung carcinogenesis in patients with and without chronic obstructive pulmonary disease

Junya Fujimoto, Humam Kadara, Carmen Behrens, Diane Liu, J Jack Lee, Luisa M. Solis, Edward Kim, Amir Sharafkhaneh, Ignacio I. Wistuba, Lotan Reuben
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2203.
https://doi.org/10.1158/1538-7445.AM2011-2203
Published: 15 April 2011
View articletitled, Abstract 2203: Implication of GPRC5A loss in lung carcinogenesis in patients with and without chronic obstructive pulmonary disease
Journal Articles

Abstract 1122: Insulin receptor expression and survival of patients with non-small cell lung cancer

Jin-Soo Kim, Edward S. Kim, Diane Liu, J. Jack Lee, Luisa Solis, Carmen Behrens, Scott Lippman, Waun Ki Hong, Ignacio I. Wistuba, Ho-Young Lee
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 1122.
https://doi.org/10.1158/1538-7445.AM2011-1122
Published: 15 April 2011
View articletitled, Abstract 1122: Insulin receptor expression and survival of patients with non-small cell lung cancer
Journal Articles

Abstract #3841: TITF-1 and EGFR gene copy variations are associated with prognosis for the patients with non-small cell lung cancer

Ximing Tang, Diane Liu, Carmen Behrens, Dandan He, Menghong Sun, David Rice, J. Jack Lee, Waun Hong, Ignacio Wistuba
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 3841.
Published: 01 May 2009
View articletitled, Abstract #3841: TITF-1 and EGFR gene copy variations are associated with prognosis for the patients with non-small cell lung cancer